5 Topic Commentaries

Personalized Cancer Vaccine Linked to Three-Year Disease-Free Survival in Head and Neck Cancer

• 

  Julie E. Bauman, MD, MPH

  Head and Neck Medical Oncology

  •

  University of Arizona Cancer Center

  The data are preliminary and the sample size is small, but it is promising.

  Source
• 

  Catherine J. Wu, MD

  Medical Oncology and Cancer Immunology

  •

  Harvard Medical School and Dana-Farber Cancer Institute

  One study is in kidney cancer, and the others are in squamous cell carcinoma, bladder cancer, and lung cancer.

  Source
• 

  Jedd D. Wolchok, MD, PhD

  Medical Oncology (Immunotherapy)

  •

  Memorial Sloan Kettering Cancer Center

  And these are vaccines that are actually custom designed, based upon the pattern of mutations, the genetic damage in an individual patient's tumor.

  Source
• 

  William G. Nelson, MD, PhD, DSc

  Medical Oncology

  •

  Johns Hopkins Medicine

  What they saw was a reduction in the risk of recurrence that was almost 44-45%.

  Source
• 

  Angela J. Yoon, DDS, MPH, MAMSc

  Oral and Maxillofacial Pathology (Head and Neck Oncology)

  •

  Columbia University College of Dental Medicine; Herbert Irving Comprehensive Cancer Center

  We also have plans to deliver cancer vaccine for those ‘high-risk’ individuals, which can be given after the surgery to prevent cancer from recurring.

  Source